| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 4.2% | 7.14% | 31.66% | 71/159 | 1.21% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 3.19% | 1.59% | 175% | 60/159 | 0.26% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 1.16% | -11.45% | -75.68% | 75/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 4.77% | 7.67% | 21.68% | 61/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 3.92% | 4.26% | 24.84% | 74/159 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 3.14% | 41.44% | 139.69% | 63/159 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.31% | 32.32% | -70.43% | 82/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 4.43% | 0.45% | 17.82% | 68/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 3.76% | -10.69% | 69.37% | 83/159 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 2.22% | -28.16% | 124.24% | 80/159 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.99% | -23.85% | -77.55% | 94/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 4.41% | -40% | 4.75% | 78/159 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 4.21% | -54.19% | 36.25% | 71/159 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 3.09% | -53.04% | 137.69% | 64/159 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.3% | 2% | -82.31% | 78/159 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 7.35% | -65.03% | -20.02% | 63/159 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 9.19% | 2% | 39.67% | 39/159 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 6.58% | -35.55% | -68.7% | 34/159 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-12-31 | 21.02% | 8.86% | 105.88% | 19/159 | 3.58% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-06-30 | 10.21% | 2% | -47.13% | 16/159 | 4.19% | 哈三联 | 27.17% | 行业排名> |
| 2019-12-31 | 19.31% | 28.73% | 28.73% | 21/159 | 2.53% | 汇宇制药 | 55.94% | 行业排名> |
| 2018-12-31 | 15% | 46.48% | 46.48% | 31/159 | 6.99% | 河化股份 | 45.32% | 行业排名> |
| 2017-12-31 | 10.24% | 2% | 2% | 48/159 | 9.61% | 汇宇制药 | 31.9% | 行业排名> |

微信公众号
证券之星APP



